Noven Pharmaceuticals, Inc.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 11960 SW 144 Street, Miami, Florida (FL) 33186, United States (USA)
- Operations here
- analysismanufacture
- FDA identifiers
- FEI 1000222037 · DUNS 148585441
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- NAIBioresearch Monitoring2026-02-13
- VAIDrug Quality Assurance2021-11-17
- VAIDrug Quality Assurance2018-01-26
- OAIDrug Quality Assurance2015-07-10
- NAIDrug Quality Assurance2012-09-24
- NAIBioresearch Monitoring2012-06-04
- NAIBioresearch Monitoring2010-05-06
- VAIDrug Quality Assurance2010-05-06
- NAIBioresearch Monitoring2009-02-06
- OAIDrug Quality Assurance2009-02-06
Drugs this plant is listed as making
3 distinct drugs across 14 products name this site in their FDA label.
- DextroamphetamineNoven Therapeutics, LLC
- estradiol/norethindrone acetate transdermal systemNoven Therapeutics, LLC
- methylphenidatein shortagePadagis Us Llc
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.